CANF – can-fite biopharma ltd sponsored adr (israel) (US:NASDAQ)
Stock Stats
News
Can-Fite BioPharma Ltd. (NYSE: CANF) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study
Can-Fite BioPharma Ltd. (NYSE: CANF) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602 [Yahoo! Finance]
Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602
Form 6-K Can-Fite BioPharma Ltd. For: May 09
Form 6-K Can-Fite BioPharma Ltd. For: May 06
Form 6-K Can-Fite BioPharma Ltd. For: Apr 25
Form 6-K Can-Fite BioPharma Ltd. For: Apr 15
Form EFFECT Can-Fite BioPharma Ltd.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.